Tech Company Financing Transactions
Synthego Funding Round
Synthego closed a $110 million Series C funding round on 10/24/2018. Investors included Founders Fund, 8VC and Menlo Ventures.
Transaction Overview
Company Name
Announced On
10/24/2018
Transaction Type
Venture Equity
Amount
$110,000,000
Round
Series C
Investors
Proceeds Purpose
The new funds further Synthego's mission to accelerate CRISPR capabilities for rapid and precise genome engineering in applications such as cell and gene therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Dabrowski
Browse more venture capital transactions:
Prev: 10/24/2018: Assignar venture capital transaction
Next: 10/24/2018: Filld venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs